Skip to main content
. 2023 Nov 30;12(6):e230193. doi: 10.1530/ETJ-23-0193

Figure 1.

Figure 1

Evolution of thyroglobulin antibodies and thyroid peroxidase antibodies titers during the first-line medical treatment of Graves’ disease, in relapsing patients and in nonrelapsing patients. Note the logarithmic scale was used for the representation of antibody titers. ULN, upper limit of normal.